查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612616

血糖监测市场：按产品、测试技术、应用、分销管道和最终用户 - 2025-2030 年全球预测

Blood Glucose Monitoring Market by Product, Testing Technology, Application, Distribution Channel, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年血糖监测市场价值为130.6亿美元，预计2024年将达到140.8亿美元，预计复合年增长率为8.28%，到2030年将达到228亿美元。

血糖监测市场的范围和定义涉及用于测量和追踪个人（尤其是糖尿病患者）血糖浓度的设备和技术。血糖监测对于管理糖尿病、预防併发症和确保整体健康至关重要。主要用途是供糖尿病患者个人使用，在临床实践中用于诊断目的，并且越来越多地用于连续监测。最终使用者主要是医院、诊所、居家照护机构和个人消费者。推动该市场成长要素包括全球糖尿病盛行率的上升、人们对糖尿病管理益处的认识不断提高、监测设备的技术进步以及向微创和非侵入性设备的转变。市场开拓机会包括将人工智慧与数位健康平台相结合以进行远端监测和更准确的资料分析、开发穿戴式技术以及扩展到糖尿病患者数量不断增加的新兴市场。影响成长的限制和挑战包括先进监测设备的高成本、低收入地区获得医疗保健的机会有限以及缺乏对糖尿病自我管理的认识和教育。公司将投资研究更具成本效益的解决方案，并扩展注重患者便利性和易用性的产品，例如长寿命感测器和增强的资料解释软体，我认为这可以带来创新。该市场竞争激烈且技术先进，现有企业和新参与企业都在努力争取市场占有率。潜在的创新领域包括开发完全无创的血糖监测技术、提高准确性以及与智慧型手机和智慧型手錶的集成，以及寻求与医疗保健提供者建立合作伙伴关係以改善患者的治疗结果。透过专注于个人化糖尿病管理解决方案，公司可以获得竞争优势，并顺应以人为本的医疗保健日益增长的趋势。

主要市场统计
基准年[2023] 130.6亿美元
预测年份 [2024] 140.8亿美元
预测年份 [2030] 228亿美元
复合年增长率（%） 8.28%

市场动态：揭示快速发展的血糖监测市场的关键市场洞察

供需的动态交互作用正在改变血糖监测市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 糖尿病流行与认识计划
    • 人们越来越偏好非侵入性技术
    • 家庭护理环境中连续血糖监测的需要
  • 市场限制因素
    • 血糖监测系统召回问题
  • 市场机会
    • 血糖监测系统的设计与功能的进步
    • 加强血糖监测报销
  • 市场挑战
    • 血糖监测生产运作复杂性

波特五力：驾驭血糖监测市场的策略工具

波特的五力框架是了解血糖监测市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解血糖监测市场的外部影响

外部宏观环境因素在塑造血糖监测市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解血糖监测市场的竞争格局

对血糖监测市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵血糖监测市场厂商绩效评估

FPNV定位矩阵是评估血糖监测市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了血糖监测市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对血糖监测市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 提高糖尿病盛行率和提高认识计划
      • 人们越来越青睐非侵入性血糖监测技术
      • 持续居家照护的需要
    • 抑制因素
      • 回顾血糖监测系统的负面影响
    • 机会
      • 血糖监测系统的设计与功能的进步
      • 加强血糖监测报销
    • 任务
      • 创建和操作血糖监测的复杂性
  • 市场区隔分析
    • 产品：提供自我血糖仪的个人指导
    • 测试技术：电极式血糖值监测仪被开发为携带式和家用设备的可能性
    • 应用：需要对第 1 型糖尿病进行精确连续监测的高级 CGM
    • 最终用户：提供血糖值监测仪以优化医院的临床效率和患者吞吐量
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章血糖监测市场：副产品

  • 连续血糖监测仪
    • 胰岛素帮浦
    • 感应器
    • 发送器和接收器
  • 自我或一次性监测
    • 血糖值仪
    • 采血针
    • 试纸

第七章 血糖监测市场测试技术

  • 电极式血糖值仪
  • 光电血糖值仪

第八章血糖监测市场：依应用分类

  • 妊娠糖尿病
  • 1型糖尿病
  • 2型糖尿病

第九章血糖监测市场：依通路划分

  • 离线
  • 在线的

第10章血糖监测市场：依最终用户分类

  • 居家护理
  • 医院/诊所

第十一章美洲血糖监测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太血糖监测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲血糖监测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 雅培完成 Bigfoot Biomedical 的收购
    • Dexcom 推出新型穿戴式设备，无需胰岛素即可协助管理第 2 型糖尿病
    • Astellas来製药、罗氏糖尿病护理日本公司和 Bluestar 签署合作协议，开发综合糖尿病自我管理解决方案并将其商业化
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • AdvaCare Pharma
  • Advin Health Care
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG by PHC Holdings Corporation
  • B. Braun Melsungen AG
  • BAYER AG
  • Becton, Dickinson and Company
  • Dexcom, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlySens Incorporated
  • I-SENS, Inc.
  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • LifeScan IP Holding, LLC.
  • Medtronic PLC
  • Medtrum Technologies Inc.
  • Nemaura Medical Inc.
  • Nipro Europe Group Companies
  • Nova Biomedical
  • Novo Nordisk A/s
  • NXP Semiconductors NV
  • PHC Holding Corporation
  • Prodigy Diabetes Care LLC
  • Sanofi SA
  • Senseonics Holdings Inc.
  • Sinocare Inc.
  • Teladoc Health, Inc.
  • Terumo Corporation
  • Ypsomed AG
Product Code: MRR-957C47F90031

The Blood Glucose Monitoring Market was valued at USD 13.06 billion in 2023, expected to reach USD 14.08 billion in 2024, and is projected to grow at a CAGR of 8.28%, to USD 22.80 billion by 2030.

The scope and definition of the blood glucose monitoring market pertain to devices and technologies used to measure and track glucose levels in individuals, particularly those with diabetes. Blood glucose monitoring is crucial for managing diabetes, preventing complications, and ensuring overall health. Applications primarily include personal use by individuals with diabetes, in clinical settings for diagnostic purposes, and increasingly for continuous monitoring. End-users are predominantly hospitals, clinics, home care settings, and individual consumers. Key growth factors driving this market include the rising prevalence of diabetes globally, increased awareness about the benefits of diabetes management, technological advancements in monitoring devices, and a shift towards minimally invasive and non-invasive devices. Emerging opportunities in the market include the integration of digital health platforms and AI for remote monitoring and more accurate data analytics, wearable technology development, and expansion in emerging markets where diabetes cases are on the rise. Limitations and challenges affecting growth include high costs of advanced monitoring devices, limited access to healthcare in low-income regions, and lack of awareness or education about self-management of diabetes. Companies could innovate by investing in research for more cost-effective solutions and expanding offerings that focus on patient convenience and ease of use, including long-lasting sensors and enhanced software for data interpretation. The nature of the market is highly competitive with rapid technological advances, with both established companies and new entrants striving to capture market share. Areas of potential innovation include developing fully non-invasive glucose monitoring technologies, improving accuracy and integration with smartphones and smartwatches, and pursuing collaboration with healthcare providers for improved patient outcomes. Focusing on personalized diabetes management solutions could offer companies a competitive edge and align with the growing trend towards individual-centric healthcare.

KEY MARKET STATISTICS
Base Year [2023] USD 13.06 billion
Estimated Year [2024] USD 14.08 billion
Forecast Year [2030] USD 22.80 billion
CAGR (%) 8.28%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Glucose Monitoring Market

The Blood Glucose Monitoring Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of diabetes and improved awareness programs
    • Increasing preference for non-invasive blood glucose monitoring technology
    • Need for continuous blood glucose monitoring in-home care settings
  • Market Restraints
    • Adverse recalls of blood glucose monitoring systems
  • Market Opportunities
    • Advancements in design and capabilities of blood glucose monitoring systems
    • Enhancements in the reimbursements for blood glucose monitoring
  • Market Challenges
    • Complexity in the production and operation of blood glucose monitoring

Porter's Five Forces: A Strategic Tool for Navigating the Blood Glucose Monitoring Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Glucose Monitoring Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Glucose Monitoring Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Glucose Monitoring Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Glucose Monitoring Market

A detailed market share analysis in the Blood Glucose Monitoring Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Glucose Monitoring Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Glucose Monitoring Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Glucose Monitoring Market

A strategic analysis of the Blood Glucose Monitoring Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Glucose Monitoring Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AdvaCare Pharma, Advin Health Care, ARKRAY, Inc., Ascensia Diabetes Care Holdings AG by PHC Holdings Corporation, B. Braun Melsungen AG, BAYER AG, Becton, Dickinson and Company, Dexcom, Inc., F. Hoffmann-La Roche Ltd., GlySens Incorporated, I-SENS, Inc., Insulet Corporation, Johnson & Johnson Services, Inc., LifeScan IP Holding, LLC., Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Nipro Europe Group Companies, Nova Biomedical, Novo Nordisk A/s, NXP Semiconductors N.V., PHC Holding Corporation, Prodigy Diabetes Care LLC, Sanofi S.A., Senseonics Holdings Inc., Sinocare Inc., Teladoc Health, Inc., Terumo Corporation, and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Blood Glucose Monitoring Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Continuous Blood Glucose Monitors and Self or One Time Monitors. The Continuous Blood Glucose Monitors is further studied across Insulin Pumps, Sensors, and Transmitter & Receiver. The Self or One Time Monitors is further studied across Blood Glucose Meter, Lancets, and Testing Strips.
  • Based on Testing Technology, market is studied across Electrode Type Blood Glucose Monitor and Photoelectric Blood Glucose Monitor.
  • Based on Application, market is studied across Gestational Diabetes, Type 1 Diabetes, and Type 2 Diabetes.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on End-User, market is studied across Home Care and Hospital & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of diabetes and improved awareness programs
      • 5.1.1.2. Increasing preference for non-invasive blood glucose monitoring technology
      • 5.1.1.3. Need for continuous blood glucose monitoring in-home care settings
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse recalls of blood glucose monitoring systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in design and capabilities of blood glucose monitoring systems
      • 5.1.3.2. Enhancements in the reimbursements for blood glucose monitoring
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity in the production and operation of blood glucose monitoring
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Provision of personalized guidance in self-monitoring blood glucose monitors
    • 5.2.2. Testing Technology: Potential of electrode-type blood glucose monitors to be developed as portable and home-use devices
    • 5.2.3. Application: Need for sophisticated CGMs with accuracy and constant monitoring for type-1 diabetes
    • 5.2.4. End-User: Provision of blood glucose monitors that optimize clinical efficiency and patient throughput in hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Blood Glucose Monitoring Market, by Product

  • 6.1. Introduction
  • 6.2. Continuous Blood Glucose Monitors
    • 6.2.1. Insulin Pumps
    • 6.2.2. Sensors
    • 6.2.3. Transmitter & Receiver
  • 6.3. Self or One Time Monitors
    • 6.3.1. Blood Glucose Meter
    • 6.3.2. Lancets
    • 6.3.3. Testing Strips

7. Blood Glucose Monitoring Market, by Testing Technology

  • 7.1. Introduction
  • 7.2. Electrode Type Blood Glucose Monitor
  • 7.3. Photoelectric Blood Glucose Monitor

8. Blood Glucose Monitoring Market, by Application

  • 8.1. Introduction
  • 8.2. Gestational Diabetes
  • 8.3. Type 1 Diabetes
  • 8.4. Type 2 Diabetes

9. Blood Glucose Monitoring Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline
  • 9.3. Online

10. Blood Glucose Monitoring Market, by End-User

  • 10.1. Introduction
  • 10.2. Home Care
  • 10.3. Hospital & Clinics

11. Americas Blood Glucose Monitoring Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Blood Glucose Monitoring Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Blood Glucose Monitoring Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Abbott Completes Acquisition Of Bigfoot Biomedical
    • 14.3.2. Dexcom Announces Novel Wearable For Managing Type 2 Diabetes - Without Insulin
    • 14.3.3. Astellas and Roche Diabetes Care Japan Ink Partnership Agreement To Develop And Commercialize Integrated Diabetes Self-Management Solution with BlueStar
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AdvaCare Pharma
  • 3. Advin Health Care
  • 4. ARKRAY, Inc.
  • 5. Ascensia Diabetes Care Holdings AG by PHC Holdings Corporation
  • 6. B. Braun Melsungen AG
  • 7. BAYER AG
  • 8. Becton, Dickinson and Company
  • 9. Dexcom, Inc.
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. GlySens Incorporated
  • 12. I-SENS, Inc.
  • 13. Insulet Corporation
  • 14. Johnson & Johnson Services, Inc.
  • 15. LifeScan IP Holding, LLC.
  • 16. Medtronic PLC
  • 17. Medtrum Technologies Inc.
  • 18. Nemaura Medical Inc.
  • 19. Nipro Europe Group Companies
  • 20. Nova Biomedical
  • 21. Novo Nordisk A/s
  • 22. NXP Semiconductors N.V.
  • 23. PHC Holding Corporation
  • 24. Prodigy Diabetes Care LLC
  • 25. Sanofi S.A.
  • 26. Senseonics Holdings Inc.
  • 27. Sinocare Inc.
  • 28. Teladoc Health, Inc.
  • 29. Terumo Corporation
  • 30. Ypsomed AG

LIST OF FIGURES

  • FIGURE 1. BLOOD GLUCOSE MONITORING MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD GLUCOSE MONITORING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. BLOOD GLUCOSE MONITORING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. BLOOD GLUCOSE MONITORING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD GLUCOSE MONITORING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD GLUCOSE MONITORING MARKET DYNAMICS
  • TABLE 7. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SENSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TRANSMITTER & RECEIVER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY BLOOD GLUCOSE METER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY LANCETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING STRIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ELECTRODE TYPE BLOOD GLUCOSE MONITOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PHOTOELECTRIC BLOOD GLUCOSE MONITOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 155. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 162. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 175. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 177. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 184. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 191. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 198. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 205. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 212. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 219. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 226. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 233. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 238. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 239. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 240. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 245. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 246. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 247. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 253. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 254. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 259. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 260. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 261. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 266. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 267. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 268. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 273. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 280. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 281. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 282. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 287. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 288. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 289. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 294. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 295. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 296. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 301. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 302. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 303. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 308. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 309. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 310. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 311. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED KING